Huang, J., Sun, Q., Zhong, Y. et al. T-cell-mediated immunity to influenza A (H2N3): implications for caccine efficacy and cross-subtype protection. Arch Microbiol 208, 404 (2026)
Influenza A viruses pose a significant pandemic threat, with H2N3 in particular representing a subtype of particular concern due to limited population immunity and potential for zoonotic transmission. Traditional antibody-centric vaccine strategies face fundamental limitations stemming from antigenic drift and shift in hemagglutinin and neuraminidase surface proteins, necessitating annual reformulation and demonstrating reduced efficacy against mismatched strains. T-cell-mediated immunity offers a complementary approach by targeting highly conserved internal viral proteins such as nucleoprotein and matrix protein 1, thereby enabling cross-subtype protection independent of surface antigen variability. This review systematically examines the role of CD8?+?cytotoxic T lymphocytes, CD4?+?helper T cells, and tissue-resident memory T cells in controlling H2N3 influenza infection, with particular emphasis on mechanisms underlying heterosubtypic immunity. Evidence from preclinical models and human cohort studies demonstrates that pre-existing T-cell responses correlate with reduced disease severity across antigenically diverse influenza strains, even in the absence of strain-specific neutralizing antibodies. Recent advances in vaccine platforms—including viral vectors, mRNA technologies, and epitope-based approaches—show promise for inducing robust T-cell responses targeting conserved epitopes. Systems immunology and artificial intelligence-assisted epitope prediction are revolutionizing vaccine design by identifying pan-HLA-restricted epitopes with broad population coverage. However, significant challenges persist, including HLA diversity, immune senescence, absence of validated correlates of protection, and regulatory uncertainties. Collectively, this review demonstrates that integration of humoral and cellular immunity through combination vaccine strategies is essential for advancing universal influenza vaccines capable of providing durable, cross-protective immunity against both seasonal and pandemic strains, including re-emerging H2-like viruses.
See Also:
Latest articles in those days:
- Weekly US Influenza Surveillance Report: Key Updates for Week 45, ending November 14, 2026 12 hours ago
- Anatomical Compartmentalization in Chickens Drives Divergent H9N2 Influenza Evolution Toward Human Receptor Binding and Immune Escape 1 days ago
- Epidemiologic Variability and Clinical Severity Across 11 Influenza Seasons in Children 2 days ago
- Molecular Epidemiology of Clade 2.3.4.4b H5N1 High-Pathogenicity Avian Influenza in South Africa, 2025-2026 2 days ago
- Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin 2 days ago
[Go Top] [Close Window]


